Saarland University Medical Center and Saarland University Faculty of Medicine
Internal Medicine IV - Nephrology and Hypertension
Director: Univ.-Professor Dr. Danilo Fliser
You are here: >> Startseite >> Klinische Zentren und Einrichtungen >> Departments and Institutes >> Medizinische Kliniken >> Internal Medicine IV

Internal Medicine IV - Nephrology and Hypertension



Prof. Dr. Danilo Fliser


Tel.: +49 6841/16-23526
Fax:  +49 6841/16-23540







The Department of Internal Medicine IV provides medical care for patients suffering from renal disease and hypertension. The department, which has been in existence for many years, is also home to the only university chair in nephrology in Saarland and Rhineland Palatinate. Equipped with advanced medical technology, our department is able to provide the highest quality diagnostic and therapeutic interventions for patients with renal and hypertensive disorders. We also run risk-factor consultation sessions to teach preventive strategies concerning in particular: hypertension, fat metabolism, excess weight, sedentary lifestyles, stress and medication. Patients found to be already suffering from advanced renal insufficiency will receive expert advice and, where necessary, will undergo kidney replacement therapy such as haemodialysis, peritoneal dialysis or kidney transplantation. Transplantations are carried out in cooperation with the Department of Urology. Besides receiving professional inpatient treatment, patients are also supervised in our numerous specialist consulting sessions. The research carried out at the department is mainly focused on cardiovascular complications in cases of chronic renal insufficiency, and infection monitoring in immunosuppressed patients. Our research programmes are supported by the German Research Council (DFG), the Else Kröner-Fresenius Foundation, the German José Carreras Leukaemia Foundation and other project-specific funds.




New Paper

Emrich IE, Vodovar N, Feuer L, Untersteller K, Nougue H, Seiler-Mussler S, Fliser D, Launay JM, Heine GH.

Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?

Nephrol Dial Transplant. 2018. Impact factor: 4.5 Abstract

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Bohm M, Marx N, Floege J, Fliser D, Jankowski J.

The new SFB/TRR219 Research Centre.

Eur Heart J. 2018;39(12):975-977. Impact factor: 20.2 Abstract

Speer T, Schunk SJ, Zewinger S.

Potassium: an ion with dangerous airs and graces.

Eur Heart J. 2018. Impact factor: 20.2 Abstract

Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH.

Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.

Clin J Am Soc Nephrol. 2018;13(4):569-576. Impact factor: 4.8 Abstract

Building 40.2



European Renal and Cardiovascular Medicine


European Uremic Toxin Work Group


Wissenschaftliches Institut für Nephrologie